Arabia, et al. v. Infinity Diagnostics Laboratory, Inc.

YOU MAY BE ENTITLED TO A CASH BENEFIT IF YOU ARE A NEW JERSEY CITIZEN WHO, BETWEEN MARCH 1, 2020, AND THE PRESENT, PURCHASED A FINGER-STICK ANTIBODY BLOOD TEST FOR COVID-19 THAT WAS ADMINISTERED AND SOLD IN NEW JERSEY BY INFINITY DIAGNOSTICS LABORATORY, INC., OR ITS EMPLOYEES.

A lawsuit entitled Arabia, et al. v. Infinity Diagnostics Laboratory, Inc., Docket No. ATL-L-3962-20, was filed in the Superior Court of New Jersey, Atlantic County on behalf of all New Jersey citizens who purchased a finger-stick antibody blood test for COVID-19 that was administered and sold in New Jersey by Infinity Diagnostics Laboratory, Inc. (“Infinity”) or its employees between March 1, 2020, and the present. The lawsuit alleges that Infinity fraudulently sold and administered these finger-stick antibody blood tests as “rapid blood tests” capable of diagnosing active cases of COVID-19, despite the fact that the tests did not and could not diagnose COVID-19. The lawsuit seeks to obtain refunds for class members who paid money for such allegedly fraudulent tests. Infinity denies the claims and allegations asserted by Plaintiffs, denies any wrongdoing or liability to Plaintiffs and the class whatsoever, and maintains that it has fully complied with New Jersey law in all its dealings with Plaintiffs and the class. The parties nevertheless have agreed to settle the lawsuit on a class-wide basis, and the proposed class settlement has now been preliminarily approved by the Court.